My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2024_OpioidSettlemtAgrmt_JanssenJJ
>
Meetings
>
2024
>
04. April
>
2024-04-16 10:00 AM - Commissioners' Agenda
>
2024_OpioidSettlemtAgrmt_JanssenJJ
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/11/2024 1:10:33 PM
Creation date
4/11/2024 1:08:48 PM
Metadata
Fields
Template:
Meeting
Date
4/16/2024
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Accepting the Johnson & Johnson (Janssen) Washington State State-Wide Opioid Settlement Agreement
Order
7
Placement
Consent Agenda
Row ID
116716
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
127
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br />J-7 <br /> <br /> <br />1. Ensure that health care providers are screening for OUD and other risk factors and <br />know how to appropriately counsel and treat (or refer if necessary) a patient for OUD <br />treatment. <br />2. Fund SBIRT programs to reduce the transition from use to disorders, including <br />SBIRT services to pregnant women who are uninsured or not eligible for Medicaid. <br />3. Provide training and long-term implementation of SBIRT in key systems (health, <br />schools, colleges, criminal justice, and probation), with a focus on youth and young <br />adults when transition from misuse to opioid disorder is common. <br />4. Purchase automated versions of SBIRT and support ongoing costs of the technology. <br />5. Expand services such as navigators and on-call teams to begin MAT in hospital <br />emergency departments. <br />6. Provide training for emergency room personnel treating opioid overdose patients on <br />post-discharge planning, including community referrals for MAT, recovery case <br />management or support services. <br />7. Support hospital programs that transition persons with OUD and any co-occurring <br />SUD/MH conditions, or persons who have experienced an opioid overdose, into <br />clinically appropriate follow-up care through a bridge clinic or similar approach. <br />8. Support crisis stabilization centers that serve as an alternative to hospital emergency <br />departments for persons with OUD and any co-occurring SUD/MH conditions or <br />persons that have experienced an opioid overdose. <br />9. Support the work of Emergency Medical Systems, including peer support specialists, <br />to connect individuals to treatment or other appropriate services following an opioid <br />overdose or other opioid-related adverse event. <br />10. Provide funding for peer support specialists or recovery coaches in emergency <br />departments, detox facilities, recovery centers, recovery housing, or similar settings; <br />offer services, supports, or connections to care to persons with OUD and any co- <br />occurring SUD/MH conditions or to persons who have experienced an opioid <br />overdose. <br />11. Expand warm hand-off services to transition to recovery services. <br />12. Create or support school-based contacts that parents can engage with to seek <br />immediate treatment services for their child; and support prevention, intervention, <br />treatment, and recovery programs focused on young people. <br />13. Develop and support best practices on addressing OUD in the workplace. <br />14. Support assistance programs for health care providers with OUD.
The URL can be used to link to this page
Your browser does not support the video tag.